glp 1 mounjaro (tirzepatide) is a dual incretin agonist targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to Microdosing GLP-1's for Weight Loss

As such, these findings suggest that AOD 9604 could be a potential therapeutic candidate for obesity (3)

Research progress of extracellular vesicles and exosomes derived from mesenchymal stem cells in the treatment of oxidative stress-related diseases

The continuous advancement of research in this area may shed further light on BPC-157s therapeutic properties, offering exciting possibilities for future medical treatments and improved healing mechanisms

Different genetic variants are associated with increased or decreased responses to GLP-1 RA drugs for diabetes or weight loss

GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)

48hr dispatch from Dallas, TX Lot ID printed on every vial label UPS Ground, tracked + insured Every step above can be verified for any specific lot by emailing [email protected] with the lot number from your vial label